There are 2789 resources available
176P - Pathological complete response to neoadjuvant systemic therapy in 1160 initial and locally advanced breast cancer patients: Real life data on outcomes
Presenter: Monique Tavares
Session: ePoster Display
Resources:
Abstract
290P - Treatment with tyrosine kinase inhibitors (TKIs) based therapy in trastuzumab emtansine (T-DM1) resistant HER2-positive metastatic breast cancer: A real-world study
Presenter: Yijia Hua
Session: ePoster Display
291P - HER2-low metastatic breast cancer (MBC): Management and prognosis of a new breast cancer entity in a real-world setting
Presenter: Jean-Sebastien Frenel
Session: ePoster Display
180P - Relapse pattern after neoadjuvant treatment in early breast cancer
Presenter: Ariadna Gasol Cudos
Session: ePoster Display
181P - Pegylated liposomal doxorubicin (PLD) combined with docetaxel and trastuzumab in neoadjuvant treatment for HER2-positive breast cancer: A multicenter, randomized, phase II, open-label trial
Presenter: Zhenchuan Song
Session: ePoster Display
182P - Correlation between TILs, ALDH1 and PD-L1 expression in triple-negative (TN) and HER2-positive (HER2+) breast cancer (BC)
Presenter: Mariana Lopez
Session: ePoster Display
195P - A prognostic signature based on two-miRNA and pathological data in early-stage HER2+ breast cancer patients
Presenter: Anna Adam Artigues
Session: ePoster Display
196P - Targeting ESR1 in breast cancer treatment: Repurposing of statins
Presenter: Eva Rahman Kabir
Session: ePoster Display
295P - Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi)
Presenter: Lucia Bortot
Session: ePoster Display
296P - Recapitulation of organ-specific breast cancer metastasis using an engineered multi-tissue platform
Presenter: Alan Chramiec
Session: ePoster Display